openPR Logo
Press release

Gavriel Dardashti Details Ibogaine Protocol Enhancements, Joined by Neuroscientist Misty Huckabey, at 2025 Denver Psychedelic Conference

04-30-2025 09:32 PM CET | Health & Medicine

Press release from: ABNewswire

Gavriel Dardashti Details Ibogaine Protocol Enhancements,

PLANTATION, FL - April 30, 2025 - Representing Ibogaine by David Dardashti, Gavriel Dardashti will detail significant neuroscientific advancements enhancing ibogaine therapy protocols at the influential 2025 Psychedelic Conference in Denver, Colorado. Building on the foundational work of his father, founder David Dardashti, the presentation showcases how sophisticated technology refines and personalizes treatment, marking a step forward in psychedelic medicine.

Gavriel, whose work bridges neuroscience technology and therapy, will explain research frameworks and bio-monitoring tools used at the center. He'll detail how real-time data analysis improves therapeutic precision, safety, and efficacy. This data-driven approach informs key innovations, including:

*
Neuro-Integrated Psychological Profiling: Correlating neurofeedback data with Jungian archetype frameworks to provide clinicians richer patient insights for more resonant guidance.

*
Optimized Integrative Psychotherapy: Utilizing brain monitoring to identify optimal windows for psychotherapeutic intervention and track integration progress post-ibogaine.

*
Tailored Neuro-Adaptive Protocols: Applying neuroscientific insights to develop specialized treatment adjustments for individuals with complex needs such as Borderline Personality Disorder (BPD) and Autism spectrum conditions, enhancing personalization and tolerability.

"The true potential of ibogaine therapy is unlocked when we combine profound respect for the patient's inner journey with objective, scientifically-grounded insights," stated Gavriel Dardashti. "By meticulously applying neuroscientific tools, we're actively refining the therapeutic process in real-time. This allows us to better support deep psychological integration, like that informed by Jungian concepts, and create genuinely personalized protocols for diverse needs."

Neuroscientist Misty Huckabey joins Mr. Dardashti, bringing valuable perspective from the broader field of psychedelic neuroscience. She will contextualize the specific applications presented by Gavriel within the larger landscape of ongoing research, discussing converging evidence and fundamental neuroscience principles underpinning these strategies. Her participation underscores the importance of integrating specific clinical advancements with wider scientific understanding.

These technological integrations represent a significant evolution of the pioneering spirit established by David Dardashti at Ibogaine by David Dardashti. The organization remains committed to research-driven, ethical ibogaine use, and Gavriel Dardashti's focus on neuroscientific validation represents the next chapter in this mission. The prestigious 2025 Psychedelic Conference provides an ideal platform for sharing these advancements with leading researchers, clinicians, and experts in the field.

About Ibogaine by David Dardashti:

Founded by the visionary David Dardashti, Ibogaine by David Dardashti stands as a beacon in the ethical and effective application of ibogaine therapy. Based in Plantation, Florida, the center integrates time-honored therapeutic wisdom with cutting-edge neuroscientific research, spearheaded by Gavriel Dardashti's technical expertise. Their comprehensive approach aims not just at symptom alleviation but at fostering profound personal transformation and sustained well

Media Contact
Company Name: Ibogaine By David Dardashti
Contact Person: Cole Barressi
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=gavriel-dardashti-details-ibogaine-protocol-enhancements-joined-by-neuroscientist-misty-huckabey-at-2025-denver-psychedelic-conference]
Country: United States
Website: http://www.ibogaineclinic.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gavriel Dardashti Details Ibogaine Protocol Enhancements, Joined by Neuroscientist Misty Huckabey, at 2025 Denver Psychedelic Conference here

News-ID: 3995372 • Views:

More Releases from ABNewswire

Sensorineural Hearing Loss Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Sensorion, Fennec Pharma, Sound Pharma, Decibel Therapeutics, Akouos
Sensorineural Hearing Loss Pipeline 2025: Key Companies, MOA, ROA, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Sensorineural Hearing Loss pipeline constitutes 20+ key companies continuously working towards developing 21+ Sensorineural Hearing Loss treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Sensorineural Hearing Loss Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/sensorineural-hearing-loss-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Sensorineural Hearing Loss Market. The
Bad Communication, Not High Prices, Is the Real Problem in HVAC Industry, New Survey Reveals
Bad Communication, Not High Prices, Is the Real Problem in HVAC Industry, New Su …
National study finds homeowners are nearly twice as likely to be frustrated by poor service and scheduling than by the final bill. AVENTURA, FL - September 11, 2025 - For decades, the HVAC industry has competed on price. A new national survey of 1,000 U.S. homeowners from FIELDBOSS, a leading HVAC software provider, reveals this focus may be misplaced. The study found homeowners are nearly twice as likely to cite poor
Huntington's Disease Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Spark therapeutics, Chong Kun Dang Pharma, Neuvivo, UniQure Biopharma
Huntington's Disease Pipeline 2025: Latest FDA Approvals, Clinical Trials, and E …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Huntington's Disease pipeline constitutes 20+ key companies continuously working towards developing 20+ Huntington's Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Huntington's Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
Regions Clinic Introduces Mounjaro in Malaysia, Offering a New Solution for Chronic Weight Management and Healthier Living
Regions Clinic Introduces Mounjaro in Malaysia, Offering a New Solution for Chro …
Regions Clinic Aesthetic & Laser Centre today announced it will be among the first clinics in Malaysia to offer Mounjaro Registered (tirzepatide), a novel, once-weekly injectable prescription medicine for chronic weight management. This announcement follows the recent regulatory approval of the medication by the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia. The medication is approved for adults with obesity (Body Mass Index [BMI] greater than or equal to 30

All 5 Releases


More Releases for Dardashti

Gavriel Dardashti, Son of Ibogaine by David Dardashti CEO, to Showcase Google Cl …
Leveraging Google Cloud, the Proposed Technology Aims to Provide Accessible Mental Wellness Insights and Track Long-Term Patient Progress, Potentially Correlating with Ibogaine Treatment Outcomes HOLLYWOOD, FL - April 8, 2025 - Gavriel Dardashti, an innovator in the wellness technology space and son of David Dardashti, CEO of Ibogaine by David Dardashti, has announced his attendance at the upcoming Google Next '25 conference. During the event, Mr. Dardashti plans to engage with
Ibogaine By David Dardashti Offers a Solution to Parkinsons
Ibogaine By David Dardashti today announced that preliminary research suggests ibogaine, a naturally occurring psychoactive alkaloid found in the root bark of the Tabernanthe iboga plant, may hold potential for treating Parkinson's disease. While some studies indicate ibogaine could impact the neurotransmitter systems involved in Parkinson's, the organization emphasizes the need for significantly more research to fully understand its effects and potential risks. Parkinson's disease is a chronic and progressive neurodegenerative
Ibogaine by David Dardashti Explores Electrodynamics Based Quantum Computing
Gavriel Dardashti, son of renowned expert in ibogaine treatment and founder of Ibogaine by David Dardashti, is attending the Adaptive Quantum Circuits events to explore the potential of quantum technology in revolutionizing mental health care. Dardashti is specifically interested in leveraging quantum computing's power to develop a user-friendly mobile app that supports individuals in managing their mental well-being during the critical months following ibogaine treatment. Ibogaine, a naturally occurring psychoactive substance,
Gavriel Dardashti Unveils Electrodynamics Hyperspace Circuit for Quantum Computi …
Gavriel Dardashti, a visionary in the field of theoretical physics, has achieved a significant breakthrough with the development of the first functional prototype circuit utilizing electrodynamics in eleven-dimensional hyperspace. This revolutionary circuit, while currently in its basic stage, demonstrates the feasibility of harnessing hyperspace principles for practical applications, particularly in the realm of quantum computing. Dardashti's innovation addresses a critical challenge in quantum computing: overheating. By implementing a more natural and
Ibogaine By David Dardashti Revolutionizes Treatment with Groundbreaking Softwar …
Ibogaine By David Dardashti is proud to announce the launch of its revolutionary software platform designed to optimize ibogaine treatment for addiction, trauma, and depression. This cutting-edge software leverages advanced mathematical modeling and statistical analysis to personalize ibogaine dosing for maximum efficiency and safety. Unparalleled Precision in Ibogaine Dosing Ibogaine By David Dardashti's software utilizes triple integrals to model bioavailability factors, ensuring that the optimal amount of ibogaine is delivered to the
Instruction on Quadratic Formula to High School Students by Gavriel Dardashti
Teaching the quadratic formula to high school students is an effective method that can highlight a teacher's skill in simplifying intricate ideas into comprehensible segments. By illustrating the sequential procedure of resolving quadratic equations using the formula, teachers can assist students in understanding the fundamental principles of algebra and problem-solving. This not only improves students' comprehension of mathematics but also cultivates critical thinking abilities and self-assurance in handling difficult problems. Moreover,